25- Hydroxyvitamin D Levels in Pregnancy and Effects on Pregnancy Related Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

249 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2018-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of 25- Hydroxyvitamin D levels in pregnant women in Austria and potential related disorders

Hypothesis:

Austrian pregnant women are Vitamin D deficient Present vitamin D supplementation in pregnancy is insufficient Vitamin D deficiency is associated with pregnancy related disorders like preeclampsia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitamin d Deficiency Preeclampsia Preterm Delivery Gestational Hypertension Gestational Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age\> 18 years
* informed consent

Exclusion Criteria

* chronic hypertension
* kidney disease
* lupus erythematodes
* diabetes mellitus
* malabsorption syndrome
* hyperparathyroidism
* surgery on the thyroid gland

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Julia Wild, MD

Dr. med. univ

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Harald Zeisler, Univ. Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

MUV

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Obstetrics and fetomaternal Medicine, Medical University of Vienna

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

V02

Identifier Type: -

Identifier Source: org_study_id